ATE77560T1 - Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen. - Google Patents

Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen.

Info

Publication number
ATE77560T1
ATE77560T1 AT89101215T AT89101215T ATE77560T1 AT E77560 T1 ATE77560 T1 AT E77560T1 AT 89101215 T AT89101215 T AT 89101215T AT 89101215 T AT89101215 T AT 89101215T AT E77560 T1 ATE77560 T1 AT E77560T1
Authority
AT
Austria
Prior art keywords
acetamide
oxo
pyrrolidin
human
filtration rate
Prior art date
Application number
AT89101215T
Other languages
English (en)
Inventor
H-U Prof Dr Med Habil Schultz
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Application granted granted Critical
Publication of ATE77560T1 publication Critical patent/ATE77560T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89101215T 1988-02-02 1989-01-25 Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen. ATE77560T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3802996A DE3802996A1 (de) 1988-02-02 1988-02-02 Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen
EP89101215A EP0329961B1 (de) 1988-02-02 1989-01-25 Verwendung von 2-Oxo-pyrrolidin-1-acetamid zur Bestimmung der glomerulären Filtrationsrate beim Menschen

Publications (1)

Publication Number Publication Date
ATE77560T1 true ATE77560T1 (de) 1992-07-15

Family

ID=6346429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101215T ATE77560T1 (de) 1988-02-02 1989-01-25 Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen.

Country Status (6)

Country Link
US (1) US4908202A (de)
EP (1) EP0329961B1 (de)
JP (1) JPH01226829A (de)
AT (1) ATE77560T1 (de)
DE (2) DE3802996A1 (de)
ES (1) ES2041845T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5301673A (en) * 1991-11-18 1994-04-12 Massachusetts General Hospital Ambulatory clearance function monitor
US5865763A (en) * 1996-08-13 1999-02-02 St. Luke's-Roosevelt Hospital Method for estimating creatinine clearance in obese and malnourished subjects using measurements of body cell mass
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
CA2544678C (en) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
GB0507838D0 (en) * 2005-04-18 2005-05-25 Epsom & St Helier University H A method of measuring the glomerular filtration rate of an human or animal patient, a self-use kit for providing blood samples for use in measuring glomerular
DK2444079T3 (en) 2005-05-17 2017-01-30 Sarcode Bioscience Inc Compositions and Methods for the Treatment of Eye Diseases
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
WO2009128934A1 (en) 2008-04-15 2009-10-22 Sarcode Corporation Topical lfa-1 antagonists for use in localized treatment of immune related disorders
US20090257957A1 (en) * 2008-04-15 2009-10-15 John Burnier Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
KR20200108932A (ko) 2012-07-25 2020-09-21 에스에이알코드 바이오사이언스 인코포레이티드 Lfa-1 저해제 및 그의 다형체
CN103462886B (zh) * 2013-09-13 2015-05-13 四川鼎诺泰宸科技有限公司 稳定的左乙拉西坦注射液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224641A1 (de) * 1982-07-01 1984-01-05 Walle Alexander Dr Verfahren zur bestimmung von glomerulaeren filtrationsraten

Also Published As

Publication number Publication date
EP0329961A2 (de) 1989-08-30
DE58901722D1 (de) 1992-07-30
DE3802996A1 (de) 1989-08-10
ES2041845T3 (es) 1993-12-01
JPH01226829A (ja) 1989-09-11
EP0329961A3 (en) 1990-10-31
EP0329961B1 (de) 1992-06-24
US4908202A (en) 1990-03-13

Similar Documents

Publication Publication Date Title
DE3782082D1 (de) Geraet zur bestimmung der temperaturempfindlichkeit des peripheren nervensystems beim menschen.
FI924773A7 (fi) Elävän ihon yhdistelmäkorvikkeita
DE3482625D1 (de) Probenahme und bestimmung von okkultem blut in derselben.
MX7531E (es) Proceso biotecnologico para alterar la proliferacion y/o el desarrollo de cultivos tisulares
LV11068A (lv) Panemiens jonu noteiksanai skidrumos
DE3880118D1 (de) Verwendung eines mittels in form von mikrokapseln zur schabenbekaempfung.
DK90089A (da) Hudbehandlingspraeparat
ATE77560T1 (de) Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen.
DE69721120D1 (de) Verwendung von menschlichen Chemokin beta-9 zur Behandlung von Atemnotsyndrom bei Erwachsenen
DE68904358D1 (de) Prostaglandinanaloge zur verwendung in der medizin.
DE3888953D1 (de) Verwendung von cellulase beim nassvermahlen.
DE3679912D1 (de) Geraet zur unblutigen tauglichkeitspruefung des kniegelenkes am lebenden menschen.
IT1178739B (it) Perfezionamenti relativi al controllo di elementi astiformi, in particolare sigarette e/o filtri per sigarette
DE68900892D1 (de) Zusammenstellung zur behandlung der osteoporose beim menschen.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
IT1163492B (it) Procedimento per la concia delle pelli
EP0434909A3 (en) Anticoagulant and antihelminthic proteins and methods for the production and use of same
ATA160189A (de) Zubereitungen zur verwendung in der bauindustrie
GB9008215D0 (en) Improvements in or relating to the treatment of surfaces
DE3544568A1 (de) Vorrichtung zur bestimmung des absolutwerts der konzentration von salzen in der atmosphaere
IT8819079A0 (it) Composizione conciante e sua utilizzazione nei procedimenti di concia e riconcia delle pelli animali.
DE59003369D1 (de) Verwendung von Triacetin in Gleitmitteln.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
ATE96857T1 (de) Verwendung von triacetin in gleitmitteln.
ATA278089A (de) Sarg

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee